Liam C. Lopez on October 28, 2026 8:35 am The cost guidance is better than expected. If they deliver, the stock could rerate. Reply
Liam A. Taylor on October 28, 2026 8:35 am The cost guidance is better than expected. If they deliver, the stock could rerate. Reply
William Brown on October 28, 2026 8:36 am Silver leverage is strong here; beta cuts both ways though. Reply
John Johnson on October 28, 2026 8:36 am Nice to see insider buying—usually a good signal in this space. Reply
Emma Jones on October 28, 2026 8:37 am Nice to see insider buying—usually a good signal in this space. Reply
Jennifer Martin on October 28, 2026 8:38 am Interesting update on Elephant Gun Vs Human. Curious how the grades will trend next quarter. Reply
James W. Moore on October 28, 2026 8:39 am If AISC keeps dropping, this becomes investable for me. Reply
Olivia Lee on October 28, 2026 8:39 am Interesting update on Elephant Gun Vs Human. Curious how the grades will trend next quarter. Reply
Noah Williams on October 28, 2026 8:39 am Silver leverage is strong here; beta cuts both ways though. Reply
Elizabeth Jones on October 28, 2026 8:41 am Exploration results look promising, but permitting will be the key risk. Reply
Olivia Johnson on October 28, 2026 8:41 am Interesting update on Elephant Gun Vs Human. Curious how the grades will trend next quarter. Reply
Olivia Rodriguez on October 28, 2026 8:41 am Nice to see insider buying—usually a good signal in this space. Reply
Mary Brown on October 28, 2026 8:41 am Interesting update on Elephant Gun Vs Human. Curious how the grades will trend next quarter. Reply
Elizabeth Jones on October 28, 2026 8:41 am I like the balance sheet here—less leverage than peers. Reply
Oliver Williams on October 28, 2026 8:43 am I like the balance sheet here—less leverage than peers. Reply
Elijah Moore on October 28, 2026 8:44 am The cost guidance is better than expected. If they deliver, the stock could rerate. Reply
Linda Jones on October 28, 2026 8:44 am If AISC keeps dropping, this becomes investable for me. Reply
Patricia Davis on October 28, 2026 8:45 am The cost guidance is better than expected. If they deliver, the stock could rerate. Reply
Oliver R. Moore on October 28, 2026 8:45 am Nice to see insider buying—usually a good signal in this space. Reply
Amelia Garcia on October 28, 2026 8:47 am Nice to see insider buying—usually a good signal in this space. Reply
Michael Rodriguez on October 28, 2026 8:47 am Interesting update on Elephant Gun Vs Human. Curious how the grades will trend next quarter. Reply
Patricia Smith on October 28, 2026 8:47 am The cost guidance is better than expected. If they deliver, the stock could rerate. Reply
Elizabeth Jackson on October 28, 2026 8:49 am The cost guidance is better than expected. If they deliver, the stock could rerate. Reply
By Garand Thumb
By Garand Thumb
By Garand Thumb
53 Comments
The cost guidance is better than expected. If they deliver, the stock could rerate.
Good point. Watching costs and grades closely.
The cost guidance is better than expected. If they deliver, the stock could rerate.
Silver leverage is strong here; beta cuts both ways though.
Good point. Watching costs and grades closely.
Good point. Watching costs and grades closely.
Nice to see insider buying—usually a good signal in this space.
Good point. Watching costs and grades closely.
Good point. Watching costs and grades closely.
Nice to see insider buying—usually a good signal in this space.
Good point. Watching costs and grades closely.
Interesting update on Elephant Gun Vs Human. Curious how the grades will trend next quarter.
Good point. Watching costs and grades closely.
Good point. Watching costs and grades closely.
If AISC keeps dropping, this becomes investable for me.
Good point. Watching costs and grades closely.
Good point. Watching costs and grades closely.
Interesting update on Elephant Gun Vs Human. Curious how the grades will trend next quarter.
Good point. Watching costs and grades closely.
Good point. Watching costs and grades closely.
Silver leverage is strong here; beta cuts both ways though.
Exploration results look promising, but permitting will be the key risk.
Good point. Watching costs and grades closely.
Interesting update on Elephant Gun Vs Human. Curious how the grades will trend next quarter.
Good point. Watching costs and grades closely.
If AISC keeps dropping, this becomes investable for me.
Good point. Watching costs and grades closely.
Nice to see insider buying—usually a good signal in this space.
Good point. Watching costs and grades closely.
Good point. Watching costs and grades closely.
Interesting update on Elephant Gun Vs Human. Curious how the grades will trend next quarter.
Good point. Watching costs and grades closely.
I like the balance sheet here—less leverage than peers.
Good point. Watching costs and grades closely.
Good point. Watching costs and grades closely.
I like the balance sheet here—less leverage than peers.
Good point. Watching costs and grades closely.
The cost guidance is better than expected. If they deliver, the stock could rerate.
Good point. Watching costs and grades closely.
Good point. Watching costs and grades closely.
If AISC keeps dropping, this becomes investable for me.
The cost guidance is better than expected. If they deliver, the stock could rerate.
Nice to see insider buying—usually a good signal in this space.
I like the balance sheet here—less leverage than peers.
Good point. Watching costs and grades closely.
Good point. Watching costs and grades closely.
Nice to see insider buying—usually a good signal in this space.
Good point. Watching costs and grades closely.
Interesting update on Elephant Gun Vs Human. Curious how the grades will trend next quarter.
The cost guidance is better than expected. If they deliver, the stock could rerate.
Good point. Watching costs and grades closely.
The cost guidance is better than expected. If they deliver, the stock could rerate.
Good point. Watching costs and grades closely.